Market Research Logo

China Oncology Drugs Market Research Report 2018

China Oncology Drugs Market Research Report 2018

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

In the last several years, China market of Oncology Drugs developed fluctuation, with an average growth rate of 12.72%. In 2017, China Revenue of Oncology Drugs is nearly 13746 M USD and will growth at CAGR at 10% in 2025 the market size will be 29668 M USD.

This report studies the Oncology Drugs development status and future trend in China, focuses on top players in China, also splits Oncology Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.
Roche
HENGRUI
AstraZeneca
QILU
Sanofi
HANSOH
LUYE
Novartis
GuiZhou YiBai
Lunan
Eli Lilly and Company
Other

Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

On the basis of product, the Oncology Drugs market is primarily split into
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other

On the basis on the end users/applications, this report covers
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other


1 Oncology Drugs Overview
1.1 Product Overview and Scope of Oncology Drugs
1.2 Classification of Oncology Drugs by Product Category
1.2.1 China Oncology Drugs Revenue Comparison by Types (2013-2025)
1.2.2 China Oncology Drugs Revenue Market Share by Types in 2017
1.2.3 Antimetabolite
1.2.4 Alkaloid drugs
1.2.5 Hormone
1.2.6 Targeted drug
1.2.7 Platinum-based drugs
1.3 China Oncology Drugs Market by Applications/End Users
1.3.1 China Oncology Drugs Revenue and Market Share Comparison by Applications (2013-2025)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.4 China Oncology Drugs Market by Regions
1.4.1 China Oncology Drugs Market Size Comparison by Regions (2013-2025)
1.4.2 South China Oncology Drugs Status and Prospect (2013-2025)
1.4.3 East China Oncology Drugs Status and Prospect (2013-2025)
1.4.4 Southwest China Oncology Drugs Status and Prospect (2013-2025)
1.4.5 Northeast China Oncology Drugs Status and Prospect (2013-2025)
1.4.6 North China Oncology Drugs Status and Prospect (2013-2025)
1.4.7 Central China Oncology Drugs Status and Prospect (2013-2025)
1.4.8 Northwest China Oncology Drugs Status and Prospect (2013-2025)
1.5 China Market Size) of Oncology Drugs (2013-2025)
1.6 Macroscopic Indicator
1.6.1 GDP for Major Regions
1.6.2 Population and Labor Considered for Forecast
1.6.3 Disposable Income Considered for Forecast
2 China Oncology Drugs Market Competition by Players/Manufacturers
2.1 China Oncology Drugs Revenue and Share by Players/Manufacturers (2017-2018)
2.2 China Oncology Drugs Gross Margin by Players/Manufacturers (2017-2018)
2.3 China Oncology Drugs Market Competitive Situation and Trends
2.3.1 China Oncology Drugs Market Concentration Rate
2.3.2 China Oncology Drugs Market Share of Top 5 and Top 5 Players/Manufacturers
2.3.3 Mergers & Acquisitions, Expansion in China Market
2.4 China Players/Manufacturers Oncology Drugs Headquarters, Established Date, Product Types
3 China Oncology Drugs Revenue by Regions (2013-2018)
3.1 China Oncology Drugs Revenue and Market Share by Regions (2013-2018)
3.2 China Oncology Drugs Growth Rate by Regions (2013-2018)
4 China Oncology Drugs Revenue by Type/ Product Category (2013-2018)
4.1 China Oncology Drugs Revenue and Market Share by Type (2013-2018)
4.2 China Oncology Drugs Growth Rate by Type (2013-2018)
5 China Oncology Drugs Revenue by Application (2013-2018)
5.1 China Oncology Drugs Revenue and Market Share by Applications (2013-2018)
5.2 China Oncology Drugs Sales Growth Rate by Applications (2013-2018)
5.3 Market Drivers and Opportunities
6 Analysis of Oncology Drugs Industry Key Manufacturers
6.1 Roche
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Revenue, Gross Margin and Market Share
6.2 HENGRUI
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Revenue, Gross Margin and Market Share
6.3 AstraZeneca
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Revenue, Gross Margin and Market Share
6.4 QILU
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Revenue, Gross Margin and Market Share
6.5 Sanofi
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Revenue, Gross Margin and Market Share
6.6 HANSOH
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Revenue, Gross Margin and Market Share
6.7 LUYE
6.7.1 Company Profile
6.6.2 Product Information
6.7.3 Revenue, Gross Margin and Market Share
6.8 Novartis
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Revenue, Gross Margin and Market Share
6.9 GuiZhou YiBai
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Revenue, Gross Margin and Market Share
6.10 Lunan
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Revenue, Gross Margin and Market Share
6.11 Eli Lilly and Company
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 Revenue, Gross Margin and Market Share
7 Oncology Drugs Manufacturing Cost Analysis
7.1 Oncology Drugs R&D Cost Analysis
7.1.1Clinical Phase Costs
7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Other Costs Analysis
7.3 Manufacturing Process Analysis of Oncology Drugs
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oncology Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
10 Factors Influencing
10.1 Price Trend of Key Industrial Raw Material
10.2 Imports & Exports
11 China Oncology Drugs Market Size Forecast (2019-2025)
11.1 China Oncology Drugs Revenue Forecast (2019-2025)
11.2 China Oncology Drugs Revenue Forecast by Type (2019-2025)
11.3 China Oncology Drugs Revenue Forecast by Application (2019-2025)
11.4 China Oncology Drugs Revenue Forecast by Regions (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Product Picture of Oncology Drugs
Figure China Oncology Drugs Revenue (M USD) Comparison by Types (2013-2025)
Figure China Oncology Drugs Revenue Market Share by Types
Figure Antimetabolite Product Picture
Figure Alkaloid drugs Product Picture
Figure Hormone Product Picture
Figure Targeted drug Product Picture
Figure Platinum-based drugs Product Picture
Figure China Oncology Drugs Revenue (M USD) Comparison by Applications (2013-2025)
Figure China Sales Market Share (%) of Oncology Drugs by Applications in 2017
Figure Blood Cancer Examples
Figure Breast Cancer Examples
Figure Gastrointestinal Cancer Examples
Figure Prostate Cancer Examples
Figure Respiratory/Lung Cancer Examples
Figure China Oncology Drugs Revenue (M USD) Comparison by Regions (2013-2025)
Figure South China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025)
Figure East China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025)
Figure Southwest China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025)
Figure Northeast China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025)
Figure North China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025)
Figure Central China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025)
Figure Northwest China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025)
Figure China Oncology Drugs Revenue (M USD) and Growth Rate (2013-2025)
Figure GDP for Major Regions in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Fertility Rates per Woman, 1970 to 2015
Figure Average Years of Schooling of the Adult Population
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Figure Household Spending Total, Million US dollars, 2015
Figure Net National Income Total, US dollars/capita, 2017
Table China Oncology Drugs Revenue (M USD) by Players/Manufacturers (2017-2018)
Table China Oncology Drugs Revenue Market Share (%) by Players/Manufacturers (2017-2018)
Figure 2017 China Oncology Drugs Revenue Market Share (%) by Players/Manufacturers
Figure 2018 China Oncology Drugs Revenue Market Share (%) by Players/Manufacturers
Table China Market Oncology Drugs Gross Margin of Key Players/Manufacturers (2017-2018)
Figure China Market Oncology Drugs Gross Margin of Key Players/Manufacturers in 2017
Figure 2017 China Oncology Drugs Revenue Market Share (%) by Players/Manufacturers
Figure China Oncology Drugs Market Share of Top 5 Players/Manufacturers
Figure China Oncology Drugs Market Share of Top 10 Players/Manufacturers
Table China Players/Manufacturers Oncology Drugs Headquarters and Established Date
Table China Players/Manufacturers Oncology Drugs Product Category
Table China Oncology Drugs Revenue (M USD) and Market Share by Regions (2013-2018)
Table China Oncology Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Oncology Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Oncology Drugs Revenue Market Share (%) by Regions in 2017
Table China Oncology Drugs Growth Rate by Regions (2013-2018)
Table China Oncology Drugs Revenue (M USD) and Market Share by Type (2013-2018)
Table China Oncology Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Oncology Drugs by Type (2013-2018)
Figure Revenue Market Share of Oncology Drugs by Type in 2017
Table China Oncology Drugs Growth Rate by Types (2013-2018)
Figure China Oncology Drugs Sales Growth Rate by Type (2013-2018)
Table China Oncology Drugs Revenue (M USD) by Applications (2013-2018)
Table China Oncology Drugs Sales Market Share (%) by Applications (2013-2018)
Figure China Oncology Drugs Sales Market Share (%) by Applications (2013-2018)
Figure China Oncology Drugs Sales Market Share (%) by Applications in 2017
Table China Oncology Drugs Sales Growth Rate by Applications (2013-2018)
Figure China Oncology Drugs Sales Growth Rate (%) by Applications (2013-2018)
Figure Cancer Incidence by Country in 2014
Figure Cancer Mortality by Country in 2014
Figure China Cancer Incidence by Type
Table Roche Company Profile
Figure Oncology Drugs Product Picture of Roche
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of Roche 2017-2018
Table HENGRUI Company Profile
Figure Oncology Drugs Product Picture of HENGRUI
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of HENGRUI 2017-2018
Table AstraZeneca Company Profile
Figure Oncology Drugs Product Picture of AstraZeneca
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of AstraZeneca 2017-2018
Table QILU Company Profile
Figure Oncology Drugs Product Picture of QILU
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of QILU 2017-2018
Table Sanofi Company Profile
Figure Oncology Drugs Product Picture of Sanofi
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of Sanofi 2017-2018
Table HANSOH Company Profile
Figure Oncology Drugs Product Picture of HANSOH
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of HANSOH 2017-2018
Table LUYE Company Profile
Figure Oncology Drugs Product Picture of LUYE
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of LUYE 2017-2018
Table Novartis Company Profile
Figure Oncology Drugs Product Picture of Novartis
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of Novartis 2017-2018
Table GuiZhou YiBai Company Profile
Figure Oncology Drugs Product Picture of GuiZhou YiBai
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of GuiZhou YiBai 2017-2018
Table Lunan Company Profile
Figure Oncology Drugs Product Picture of Lunan
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of Lunan 2017-2018
Table Eli Lilly and Company Company Profile
Figure Oncology Drugs Product Picture of Eli Lilly and Company
Table Oncology Drugs Revenue (M USD), Gross Margin and Market Share of Eli Lilly and Company 2017-2018
Figure typical phases from research to the market for a drug candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Oncology Drugs
Figure USA Labor Cost Analysis 2013-2018
Figure Cost of Employing a Factory Worker
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe
Figure Monthly Minimum Wages in Asia 2016
Figure China Labor Costs 2013-2016
Table Average Price of Electricity to Ultimate Customers 2007-2016
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Manufacturing Process Analysis of Oncology Drugs
Figure Oncology Drugs Industrial Chain Analysis
Table Major Buyers of Oncology Drugs
Figure Marketing Channel for Biopharmaceuticals
Figure Conceptual Model of the Flow of Products, Services and Funds for Non-specialty Drugs Coveredunder Private Insurance and Purchased in a Retail Setting
Figure Marketing Channel for Biopharmaceuticals
Figure Setting Pricing Policy
Figure Price Trend of Crude Oil (USD/BBL)
Figure Price Trend of Brent Crude Oil (USD/BBL)
Figure Price Trend of Natural Gas (MMBtu)
Figure Price Trend of Gasoline (GAL)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report